FIELD: pharmaceutics.
SUBSTANCE: invention relates to cytotoxic pentapeptides of formula (I), their conjugates antibody-drug and pharmaceutical compositions.
EFFECT: compounds have anti-tumour activity and are intended for treating cancer.
28 cl, 8 dwg, 29 tbl
Title | Year | Author | Number |
---|---|---|---|
NEW CONJUGATES BINDING COMPOUND - ACTIVE COMPOUND (ADC) AND USE THEREOF | 2012 |
|
RU2610336C2 |
DERIVATIVES OF DOLAPROIN-DOLAIZOLEIN PEPTIDES | 2015 |
|
RU2747989C2 |
DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS | 2014 |
|
RU2662951C2 |
ANTIBODY AND MEDICINAL AGENT CONJUGATE AND USE THEREOF FOR TREATING CANCER | 2015 |
|
RU2685259C2 |
CONJUGATES OF MONOMETHYL AURISTATIN E WITH ASIALOGLYCOPROTEIN RECEPTOR LIGANDS FOR TARGETED TRANSPORT INTO TUMOR CELLS OF LIVER | 2022 |
|
RU2809635C1 |
COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
CONJUGATE OF ANTI-IGF-1R ANTIBODY WITH DRUG AND USE THEREOF FOR TREATING CANCER | 2015 |
|
RU2692563C2 |
LIGAND CONJUGATE WITH CYTOTOXIC DRUG PREPARATION, METHOD AND APPLICATION THEREOF | 2016 |
|
RU2708461C2 |
CYTOTOXIC AND ANTIMITOTIC COMPOUNDS AND METHODS OF USING THEM | 2015 |
|
RU2723651C2 |
DERIVATIVES OF DOLASTATIN 10 | 2002 |
|
RU2296750C2 |
Authors
Dates
2016-06-10—Published
2012-11-07—Filed